R&D
Towards a democratic era of medicine, with Simon Kohl
In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.
R&D
CDMOs: Their crucial role and how to select one, with Sigma ...
Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.
R&D
On US drug shortages and compounding pharmacies, with Shawn ...
Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.
Oncology
Delving into the physics of cancer, with Lew Bender
In a new podcast, Intensity Therapeutics' Lew Bender discusses intra-tumourally injected therapeutics - a novel approach to cancer cell death.
R&D
On inflammation, heart health, and GLP-1 possibilities, with...
Sandeep Kulkarni, CEO of Tourmaline Bio, discusses inflammation, & the impact of AI and GLP-1s on cardiology clinical trials and drug development.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
